Horizon 2020 Dedicated SME Instrument Call for Proposals

European CommissionThe specific challenge of the actions envisaged under this call could cover any aspect of the Specific Programme for Space (Horizon 2020 Framework programme and Specific programme). The SME instrument consists of three separate phases and a coaching and mentoring service for beneficiaries. Participants can apply to phase 1 with a view to applying to phase 2 at a later date, or directly to phase 2.

In phase 1, a feasibility study shall be developed verifying the technological/practical as well as economic viability of an innovation idea/concept with considerable novelty to the industry sector in which it is presented (new products, processes, design, services and technologies or new market applications of existing technologies). The activities could, for example, comprise risk assessment, market study, user involvement, Intellectual Property (IP) management, innovation strategy development, partner search, feasibility of concept and the like to establish a solid high-potential innovation proposal aligned to the enterprise strategy and with a European dimension. Bottlenecks in the ability to increase profitability of the enterprise through innovation shall be detected and analysed during phase 1 and addressed during phase 2 to increase the return in investment in innovation activities.

The proposal should contain an initial business plan based on the proposed idea/concept.

The proposal should give the specifications of the elaborated business plan, which is to be the outcome of the proposal and the criteria for success.

Funding will be provided in the form of a lump sum of EUR 50.000. Proposals should last around 6 months.

In phase 2, innovation proposals will be supported that address the challenges identified in the specific programme for space and that demonstrate high potential in terms of company competitiveness and growth underpinned by a strategic business plan. Activities should focus on innovation activities such as demonstration, testing, prototyping, piloting, scaling-up, miniaturisation, design, market replication and the like aiming to bring an innovation idea (product, process, service, etc) to industrial readiness and maturity for market introduction close to deployment and market introduction, but may also include some research. For technological innovation a Technology Readiness Levels of 6 or above (or similar for non-technological innovations) are envisaged; please see part G of the General Annexes.

Proposals shall be based on an elaborated business plan either developed through phase 1 or another means. Particular attention must be paid to IP protection and ownership; applicants will have to present convincing measures to ensure the possibility of commercial exploitation ('freedom to operate').

Proposals shall contain a specification for the outcome of the proposal, including a first commercialisation plan, and criteria for success.

The Commission considers that proposals requesting a contribution from the EU of between EUR 0.5 and 2.5 million would allow phase 2 to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts. Proposals should last between 12 and 24 months.

In addition, in phase 3, SMEs can benefit from indirect support measures and services as well as access to the financial facilities supported under Access to Risk Finance of this work programme.

For further information, please visit:

PS: Health IT Space has a networking group named HORIZON 2020 Partners, please join this group if you are looking for HORIZON 2020 announces or for enrolment into existing/forming consortia as a partner for participation in EU research projects.

For further information, please visit:
http://www.healthitspace.eu/network/groups/viewgroup/3-horizon-2020-partners

Most Popular Now

European Artificial Intelligence Act Com…

The European Artificial Intelligence Act (AI Act), the world's first comprehensive regulation on artificial intelligence, enters into force. The AI Act is designed to ensure that AI developed and used...

Generative AI can Not yet Reliably Read …

It may someday be possible to use Large Language Models (LLM) to automatically read clinical notes in medical records and reliably and efficiently extract relevant information to support patient care...

AI can Help Rule out Abnormal Pathology …

A commercial artificial intelligence (AI) tool used off-label was effective at excluding pathology and had equal or lower rates of critical misses on chest X-ray than radiologists, according to a...

Patient Safety must be Central to the De…

An EPR system brings together different patient information in one place, making it easier to access for healthcare professionals. This information can include patients' own notes, test results, observations by...

ChatGPT Shows Promise in Answering Patie…

The groundbreaking ChatGPT chatbot shows potential as a time-saving tool for responding to patient questions sent to the urologist's office, suggests a study in the September issue of Urology Practice®...

What Does the EU's Recent AI Act Me…

The European Union's law on artificial intelligence came into force on 1 August. The new AI Act essentially regulates what artificial intelligence can and cannot do in the EU. A...

Survey: Most Americans Comfortable with …

Artificial intelligence (AI) is all around us - from smart home devices to entertainment and social media algorithms. But is AI okay in healthcare? A new national survey commissioned by...

AI Spots Cancer and Viral Infections at …

Researchers at the Centre for Genomic Regulation (CRG), the University of the Basque Country (UPV/EHU), Donostia International Physics Center (DIPC) and the Fundación Biofisica Bizkaia (FBB, located in Biofisika Institute)...

Video Gaming Improves Mental Well-Being

A pioneering study titled "Causal effect of video gaming on mental well-being in Japan 2020-2022," published in Nature Human Behaviour, has conducted the most comprehensive investigation to date on the...

New Diabetes Research Links Blood Glucos…

As part of its ongoing exploration of vocal biomarkers and the role they can play in enhancing health outcomes, Klick Labs published a new study in Scientific Reports - confirming...

New AI Software could Make Diagnosing De…

Although Alzheimer's is the most common cause of dementia - a catchall term for cognitive deficits that impact daily living, like the loss of memory or language - it's not...

Machine learning helps identify rheumato…

A machine-learning tool created by Weill Cornell Medicine and Hospital for Special Surgery (HSS) investigators can help distinguish subtypes of rheumatoid arthritis (RA), which may help scientists find ways to...